News | January 13, 2012

Accuray Radiation Therapy Systems Surpasses 600 Installations Globally

January 13, 2012 — Accuray said this week there had been significant momentum in global adoption of its CyberKnife robotic radiosurgery system and TomoTherapy system. Along with the company's short and long-term growth strategy, this news was presented by Accuray President and CEO Euan Thomson, Ph.D., as part of the 30th Annual J.P. Morgan Healthcare Conference in San Francisco.

Accuray has taken its installed base from zero to over 600 commercially released systems in approximately a decade. That momentum has continued in the United States and internationally as a result of growing demand for effective and efficient radiation oncology treatments in emerging growth markets, and as the growing body of clinical evidence mounts supporting the advantages of image-guided radiosurgery and IMRT technologies.

As Accuray's earliest CyberKnife and TomoTherapy systems reach the end of their life cycle, new opportunities emerge for organic replacement business, along with the opportunity to capture the replacement market for older, pre-existing linacs at centers that desire newer, state-of-the-art capabilities. As the installed base grows, so too does Accuray's recurring revenue streams through service contracts, which together represent consistent annual growth.

By combining the two radiation oncology technologies focused on personalized patient care, Accuray has seen growing interest in both the TomoTherapy and CyberKnife technologies. The company's installations currently span 33 countries.

For more information: www.accuray.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more